Skip to content

A randomized controlled study of offline and online group metacognitive training in patients with schizophrenia

A randomized controlled study of offline and online group metacognitive training in patients with schizophrenia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096505
Enrollment
Unknown
Registered
2025-01-24
Start date
2024-01-02
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

intervention group:On the basis of the control group, they received 8-week metagegnitive group cognitive training combining online and offline
control group:Receive regular medication and basic psychiatric care

Sponsors

The Second Affiliated Hospital of Xinxiang Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age 18~60 years old, junior high school education or above, (2) Mini-Mental State Examination (MlMSE), score >24 points, can normally understand the training content. (3) Total score of Positive and Negative Syndrome Scale PANSS <=75, (4) Patients and guardians obtain written informed consent.

Exclusion criteria

Exclusion criteria: (1) A serious risk of suicide or attack; (2) Patients with severe cognitive impairment; (3) People with serious physical illness or substance abuse such as alcohol

Design outcomes

Primary

MeasureTime frame
Positive and negative symptom scale;

Secondary

MeasureTime frame
Chinese version of the delusional Characteristics Rating Scale;Chinese version of the Psychiatric Symptom Rating Scale;insight and treatment attitude questionnaire;

Countries

China

Contacts

Public ContactYanping Zhang

The Second Affiliated Hospital of Xinxiang Medical College

yf9666@126.com+86 175 2702 6984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026